Clinical Trial Update: Intravenous Immunoglobulin After Relapse in Vasculitis [Phase 3]

View source ↗

Summary

Phase 3 trial of intravenous immunoglobulin for relapse in ANCA-associated vasculitis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: ANCA + Vasculitides Relapsing Either Under Corticosteroid, and Immunosuppressant Therapies or After One Year | Phase 3 | Status: TERMINATED